Literature DB >> 28215507

Significance of uterine corpus tumor invasion in early-stage cervical cancer.

K Matsuo1, H Machida2, E A Blake3, T Takiuchi2, M Mikami4, L D Roman5.   

Abstract

OBJECTIVE: To examine characteristics and survival outcomes of women with surgically-treated cervical cancer exhibiting uterine corpus tumor invasion.
METHODS: We utilized The Surveillance, Epidemiology, and End Results Program to identify cervical cancer patients who underwent hysterectomy between 1973 and 2003. Logistic regression models were used to identify risk factors for uterine corpus tumor invasion on multivariable analysis. Association of uterine corpus tumor invasion and cause-specific survival (CSS) from cervical cancer was examined with Cox proportional hazard regression models on multivariable analysis.
RESULTS: We identified 837 (4.9%) cases of uterine corpus invasion and 16,237 (95.1%) cases of non-invasion. Median follow-up time was 14.0 years. There were 1642 deaths due to cervical cancer. Uterine corpus invasion was independently associated with older age, non-squamous histology, high-grade tumors, large tumor size, and nodal metastasis on multivariable analysis (all, P < 0.001). On univariable analysis, uterine corpus tumor invasion was significantly associated with decreased CSS compared to the non-invasion (5-year rates, 79.0% versus 94.5%, P < 0.001). After controlling for other significant prognostic factors, uterine corpus tumor invasion remained an independent prognostic factor for decreased CSS (adjusted-hazard ratio 1.45, 95% confidence interval 1.21-1.74). Among stage T1b cases (n = 6730), uterine corpus tumor invasion remained an independent prognostic factor for decreased CSS (adjusted-hazard ratio 1.95, 95%CI 1.47-2.60). Uterine corpus tumor invasion was significantly associated with decreased CSS in stage T1b1 disease (74.5% versus 90.7%, P < 0.001) and in stage T1b2 disease (67.0% versus 79.5%, P = 0.01).
CONCLUSION: Uterine corpus tumor invasion is an independent prognostic factor for decreased survival of women with early-stage cervical cancer.
Copyright © 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Lymph node metastasis; Survival outcome; Uterine corpus

Mesh:

Year:  2017        PMID: 28215507      PMCID: PMC7521086          DOI: 10.1016/j.ejso.2017.01.017

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  20 in total

1.  Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Authors:  G Delgado; B Bundy; R Zaino; B U Sevin; W T Creasman; F Major
Journal:  Gynecol Oncol       Date:  1990-09       Impact factor: 5.482

2.  Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer.

Authors:  Koji Matsuo; Hiroko Machida; Donna Shoupe; Alexander Melamed; Laila I Muderspach; Lynda D Roman; Jason D Wright
Journal:  Obstet Gynecol       Date:  2017-01       Impact factor: 7.661

3.  Ovarian metastasis from cervical carcinoma.

Authors:  H S Wu; M S Yen; C R Lai; H T Ng
Journal:  Int J Gynaecol Obstet       Date:  1997-05       Impact factor: 3.561

4.  FIGO staging for carcinoma of the vulva, cervix, and corpus uteri.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  2014-02-22       Impact factor: 3.561

5.  Local spread of cervical cancer revisited: a clinical and pathological pattern analysis.

Authors:  Michael Höckel; Thomas Kahn; Jens Einenkel; Norma Manthey; Ulf-Dietrich Braumann; Guido Hildebrandt; Cornelia Leo; Bettina Hentschel; Peter Vaupel; Lars-Christian Horn
Journal:  Gynecol Oncol       Date:  2010-03-16       Impact factor: 5.482

6.  Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study.

Authors:  Michael Höckel; Lars-Christian Horn; Helga Fritsch
Journal:  Lancet Oncol       Date:  2005-09-08       Impact factor: 41.316

7.  Tumor volume and uterine body invasion assessed by MRI for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy.

Authors:  Hunjung Kim; Woochul Kim; Mijo Lee; Eunseop Song; John J K Loh
Journal:  Jpn J Clin Oncol       Date:  2007-11-24       Impact factor: 3.019

8.  Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent.

Authors:  K Narayan; R J Fisher; D Bernshaw
Journal:  Int J Gynecol Cancer       Date:  2008 May-Jun       Impact factor: 3.437

9.  Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis.

Authors:  Michael Höckel; Lars-Christian Horn; Norma Manthey; Ulf-Dietrich Braumann; Ulrich Wolf; Gero Teichmann; Katrin Frauenschläger; Nadja Dornhöfer; Jens Einenkel
Journal:  Lancet Oncol       Date:  2009-05-29       Impact factor: 41.316

10.  Uterine corpus involvement as well as histologic type is an independent predictor of ovarian metastasis in uterine cervical cancer.

Authors:  Min-Jeong Kim; Hyun Hoon Chung; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

View more
  10 in total

1.  Characteristics and outcomes of reproductive-aged women with early-stage cervical cancer: trachelectomy vs hysterectomy.

Authors:  Hiroko Machida; Rachel S Mandelbaum; Mikio Mikami; Takayuki Enomoto; Yukio Sonoda; Brendan H Grubbs; Richard J Paulson; Lynda D Roman; Jason D Wright; Koji Matsuo
Journal:  Am J Obstet Gynecol       Date:  2018-08-21       Impact factor: 8.661

2.  Uterine corpus invasion in cervical cancer: a multicenter retrospective case-control study.

Authors:  Weili Li; Fangjie He; Ping Liu; Hui Duan; Yan Ni; Shaoguang Wang; Lihong Lin; Zhaohong Yin; Xiaolin Chen; Lu Yin; Lixia Wang; Yueping Liu; Zhonghua Luan; Chunlin Chen
Journal:  Arch Gynecol Obstet       Date:  2021-02-05       Impact factor: 2.344

3.  Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group.

Authors:  Shogo Shigeta; Muneaki Shimada; Keita Tsuji; Tomoyuki Nagai; Yasuhito Tanase; Koji Matsuo; Shoji Kamiura; Takashi Iwata; Harushige Yokota; Mikio Mikami
Journal:  Int J Clin Oncol       Date:  2022-06-14       Impact factor: 3.850

4.  Risk stratification models for para-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer.

Authors:  Koji Matsuo; Muneaki Shimada; Tsuyoshi Saito; Kazuhiro Takehara; Hideki Tokunaga; Yoh Watanabe; Yukiharu Todo; Ken Ichirou Morishige; Mikio Mikami; Toru Sugiyama
Journal:  J Gynecol Oncol       Date:  2018-01       Impact factor: 4.401

5.  Less radical surgery for women with early stage cervical cancer: Our experience on radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy.

Authors:  I Rizzuto; W MacNab; R Nicholson; M Nalam; B Rufford
Journal:  Gynecol Oncol Rep       Date:  2019-03-11

6.  Cervical carcinoma in the setting of uterovaginal prolapse: comparing standard versus tailored management.

Authors:  Ryan M Kahn; Sushmita Gordhandas; Kiersten Craig; Tanaka J Dune; Kevin Holcomb; Eloise Chapman-Davis; Melissa K Frey
Journal:  Ecancermedicalscience       Date:  2020-05-13

7.  A Case of Nonpuerperal Uterine Inversion Caused by Cervical Cancer.

Authors:  Daiki Hiratsuka; Takehiro Tsukazaki; Kenbun Sone; Kazuaki Neriishi; Kimihiro Takechi
Journal:  Case Rep Obstet Gynecol       Date:  2022-01-31

8.  Retracted Article: Long non-coding RNA NEAT1 accelerates cell progression in cervical cancer by regulating the miR-889-3p/E2F7 axis through the activation of the PI3K/AKT pathway.

Authors:  Hongmei Zhou; Ruixia Guo; Chunfang Wang
Journal:  RSC Adv       Date:  2019-10-31       Impact factor: 4.036

9.  Nomogram Predicting Lymph Node Metastasis in the Early-Stage Cervical Cancer.

Authors:  Shimin Yang; Chunli Liu; Chunbo Li; Keqin Hua
Journal:  Front Med (Lausanne)       Date:  2022-06-30

10.  Clinical analysis of HPV58-positive cervical cancer.

Authors:  Mengjie Chen; He Wang; Yuejuan Liang; Li Li
Journal:  Infect Agent Cancer       Date:  2020-06-05       Impact factor: 2.965

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.